Clinical Trials
5 trialsNCT03457389 2020-03-18
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Seoul National University Hospital
Phase NA Unknown
NCT03717454 2018-11-20
Dopamine D2 Receptors(D2R) Imaging in Prolactinomas
Ruijin Hospital
Phase NA Unknown
NCT03400865 2018-10-16
Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas
Ruijin Hospital
Phase NA Unknown
NCT03353025 2017-11-24
TNAPA
First Affiliated Hospital, Sun Yat-Sen University
Phase NA Unknown
NCT01775332 2015-07-31
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Unity Health Toronto
Phase NA Unknown